While Quanex Building Products
What analysts say:
- Buy, sell, or hold?: Analysts think investors should stand pat on Quanex Building Products with five of eight analysts rating it hold. Analysts don't like Quanex Building Products as much as competitor NCI Building Systems overall. One out of two analysts rate NCI Building Systems a buy compared to three of eight for Quanex Building Products. Quanex Building Products' rating hasn't changed over the past three months.
- Revenue forecasts: On average, analysts predict $182.9 million in revenue this quarter. That would represent a rise of 14.4% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is a loss of $0.03 per share. Estimates range from a loss of $0.10 to a profit of $0.01.
What our community says:
CAPS All-Stars are solidly behind the stock, with 95.9% giving it an "outperform" rating. The community at large backs the All-Stars, with 85.5% awarding it a rating of "outperform." Despite the majority sentiment in favor of Quanex Building Products, the stock has a middling CAPS rating of three out of five stars.
Revenue has now gone up for three straight quarters.
We can help you keep tabs on your companies with My Watchlist, our free, personalized service. Add Quanex Building Products now.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.Earnings estimates provided by Zacks.